About Aerpio.

The company behind the science.

Steve Pakola, MD - Chief Medical Officer

Steve PakolaMost recently, Dr. Pakola served as Chief Medical Officer of Amakem, a kinase platform company developing new treatments for serious eye conditions. Prior to Amakem, Dr. Pakola was Chief Medical Officer at ThromboGenics NV, where he was responsible for worldwide clinical development programs, including vitreoretinal disease and cardiovascular disease. Dr. Pakola was the lead inventor and led the development of ThromboGenics' lead product, Jetrea® from its inception through BLA submission. Jetrea® was the first product approved for vitreomacular adhesion including macular hole in the US, Europe and rest of world. Dr. Pakola previously held senior-level clinical development positions at Boehringer Ingelheim Pharmaceuticals, Inc., Quintiles, and Organon Inc. He received his B.A. with Honors in Biology and his M.D. with Honors from the University of Pennsylvania.

LinkedIn Connect with Steve